Given this uncertainty and the increasing evidence linking CBX proteins to inflammation-driven cancer progression, we focused our study on CBX4 to elucidate its expression pattern, regulatory networks, and clinical relevance in CRC. The gene discussed is CBX4; the disease is cancer.